Copyright
©The Author(s) 2023.
World J Clin Cases. May 16, 2023; 11(14): 3238-3247
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3238
Published online May 16, 2023. doi: 10.12998/wjcc.v11.i14.3238
Treatment compliance | Pharmaceutical group (n = 45) | Non-pharmaceutical group (n = 45) | χ2 | P value |
Before treatment | 0.179 | 0.673 | ||
Complete compliance | 1 (2.22) | 2 (4.44) | ||
Partial compliance | 21 (46.67) | 18 (40.00) | ||
Non-compliance | 23 (51.11) | 25 (55.55) | ||
Compliance | 22 (48.89) | 20 (44.44) | ||
After treatment | ||||
Complete compliance | 12 (26.67) | 21 (46.67) | 15.195 | < 0.001 |
Partial compliance | 20 (44.44) | 22 (48.89) | ||
Non-compliance | 13 (28.89) | 2 (4.44) | ||
Compliance | 32 (71.11) | 43 (95.56) |
- Citation: Lv YB, Cheng W, Wang MH, Wang XM, Hu YL, Lv LQ. Effect of non-pharmacological treatment on the full recovery of social functioning in patients with attention deficit hyperactivity disorder. World J Clin Cases 2023; 11(14): 3238-3247
- URL: https://www.wjgnet.com/2307-8960/full/v11/i14/3238.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i14.3238